Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-10 22:40:40 UTC |
---|
Update Date | 2021-09-26 22:54:11 UTC |
---|
HMDB ID | HMDB0245619 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | 3-(5-Methylisoxazol-3-yl)-6-[(1-methyl-1H-1,2,3-triazol-4-yl)methoxy][1,2,4]triazolo[3,4-a]phthalazine |
---|
Description | 215874-86-5, also known as ALPHA5IA CPD, belongs to the class of organic compounds known as 1,2,4-triazolo[3,4-a]phthalazines. These are aromatic heteropolycyclic compounds containing a 1,2,4-triazole fused to and sharing a nitrogen atom with the diazine ring of a phthalazine moiety. Based on a literature review very few articles have been published on 215874-86-5. This compound has been identified in human blood as reported by (PMID: 31557052 ). 3-(5-methylisoxazol-3-yl)-6-[(1-methyl-1h-1,2,3-triazol-4-yl)methoxy][1,2,4]triazolo[3,4-a]phthalazine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 3-(5-Methylisoxazol-3-yl)-6-[(1-methyl-1H-1,2,3-triazol-4-yl)methoxy][1,2,4]triazolo[3,4-a]phthalazine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | CN1C=C(COC2=NN3C(=NN=C3C3=CC=CC=C23)C2=NOC(C)=C2)N=N1 InChI=1S/C17H14N8O2/c1-10-7-14(22-27-10)16-20-19-15-12-5-3-4-6-13(12)17(21-25(15)16)26-9-11-8-24(2)23-18-11/h3-8H,9H2,1-2H3 |
---|
Synonyms | Value | Source |
---|
3-(5-Methylisoxazol-3-yl)-6-((1-methyl-1,2,3-triazol-4-yl)methyloxy)-1,2,4-triazolo(3,4-a)phthalazine | MeSH | alpha5IA CPD | MeSH |
|
---|
Chemical Formula | C17H14N8O2 |
---|
Average Molecular Weight | 362.353 |
---|
Monoisotopic Molecular Weight | 362.123971723 |
---|
IUPAC Name | 1-methyl-4-({[3-(5-methyl-1,2-oxazol-3-yl)-[1,2,4]triazolo[3,4-a]phthalazin-6-yl]oxy}methyl)-1H-1,2,3-triazole |
---|
Traditional Name | Α5IA |
---|
CAS Registry Number | Not Available |
---|
SMILES | CN1C=C(COC2=NN3C(=NN=C3C3=CC=CC=C23)C2=NOC(C)=C2)N=N1 |
---|
InChI Identifier | InChI=1S/C17H14N8O2/c1-10-7-14(22-27-10)16-20-19-15-12-5-3-4-6-13(12)17(21-25(15)16)26-9-11-8-24(2)23-18-11/h3-8H,9H2,1-2H3 |
---|
InChI Key | NZMJFRXKGUCYNP-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 1,2,4-triazolo[3,4-a]phthalazines. These are aromatic heteropolycyclic compounds containing a 1,2,4-triazole fused to and sharing a nitrogen atom with the diazine ring of a phthalazine moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Diazanaphthalenes |
---|
Sub Class | Benzodiazines |
---|
Direct Parent | 1,2,4-triazolo[3,4-a]phthalazines |
---|
Alternative Parents | |
---|
Substituents | - 1,2,4-triazolo[3,4-a]phthalazine
- Phthalazinone
- Alkyl aryl ether
- Benzenoid
- Pyridazine
- Azole
- Isoxazole
- Heteroaromatic compound
- 1,2,4-triazole
- 1,2,3-triazole
- Ether
- Oxacycle
- Azacycle
- Organic nitrogen compound
- Organooxygen compound
- Organonitrogen compound
- Hydrocarbon derivative
- Organopnictogen compound
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedMetabolite | SMILES | Kovats RI Value | Column Type | Reference |
---|
3-(5-Methylisoxazol-3-yl)-6-[(1-methyl-1H-1,2,3-triazol-4-yl)methoxy][1,2,4]triazolo[3,4-a]phthalazine | CN1C=C(COC2=NN3C(=NN=C3C3=CC=CC=C23)C2=NOC(C)=C2)N=N1 | 3774.6 | Standard polar | 33892256 | 3-(5-Methylisoxazol-3-yl)-6-[(1-methyl-1H-1,2,3-triazol-4-yl)methoxy][1,2,4]triazolo[3,4-a]phthalazine | CN1C=C(COC2=NN3C(=NN=C3C3=CC=CC=C23)C2=NOC(C)=C2)N=N1 | 3414.4 | Standard non polar | 33892256 | 3-(5-Methylisoxazol-3-yl)-6-[(1-methyl-1H-1,2,3-triazol-4-yl)methoxy][1,2,4]triazolo[3,4-a]phthalazine | CN1C=C(COC2=NN3C(=NN=C3C3=CC=CC=C23)C2=NOC(C)=C2)N=N1 | 3600.9 | Semi standard non polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 3-(5-Methylisoxazol-3-yl)-6-[(1-methyl-1H-1,2,3-triazol-4-yl)methoxy][1,2,4]triazolo[3,4-a]phthalazine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4m-9362000000-016d5024ca4cdbb18e52 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 3-(5-Methylisoxazol-3-yl)-6-[(1-methyl-1H-1,2,3-triazol-4-yl)methoxy][1,2,4]triazolo[3,4-a]phthalazine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-(5-Methylisoxazol-3-yl)-6-[(1-methyl-1H-1,2,3-triazol-4-yl)methoxy][1,2,4]triazolo[3,4-a]phthalazine 10V, Positive-QTOF | splash10-03di-0009000000-a56d07d28bfad52561c3 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-(5-Methylisoxazol-3-yl)-6-[(1-methyl-1H-1,2,3-triazol-4-yl)methoxy][1,2,4]triazolo[3,4-a]phthalazine 20V, Positive-QTOF | splash10-03di-0009000000-4f93ecba0d63cfb1fcc6 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-(5-Methylisoxazol-3-yl)-6-[(1-methyl-1H-1,2,3-triazol-4-yl)methoxy][1,2,4]triazolo[3,4-a]phthalazine 40V, Positive-QTOF | splash10-0a4l-3294000000-ca211fbeb4d66239110f | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-(5-Methylisoxazol-3-yl)-6-[(1-methyl-1H-1,2,3-triazol-4-yl)methoxy][1,2,4]triazolo[3,4-a]phthalazine 10V, Negative-QTOF | splash10-03di-0009000000-386a05fb1bb0db046913 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-(5-Methylisoxazol-3-yl)-6-[(1-methyl-1H-1,2,3-triazol-4-yl)methoxy][1,2,4]triazolo[3,4-a]phthalazine 20V, Negative-QTOF | splash10-0ik9-0019000000-c55b36903c64c0ed6a5c | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 3-(5-Methylisoxazol-3-yl)-6-[(1-methyl-1H-1,2,3-triazol-4-yl)methoxy][1,2,4]triazolo[3,4-a]phthalazine 40V, Negative-QTOF | splash10-0gb9-0090000000-665678c6988488e28e9e | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|